Sleep-Disordered Breathing in Chronic Thromboembolic Pulmonary Hypertension

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Chronic Thromboembolic Pulmonary HypertensionSleep Disordered Breathing
Interventions
DRUG

Riociguat

Patients will be treated with Riociguat according to guidelines (2015 ERS/ESC guidelines for the diagnosis and treatment of pulmonary hypertension) and manufacturers recommendation.

PROCEDURE

Pulmonary Endarteriectomy

Patients will receive Pulmonary Endarteriectomy if they are suitable for this procedure according to the recommendation of the local CTEPH board. Patients must also consent to this surgical procedure.

PROCEDURE

Ballon Pulmonary Angioplasty

Patients will receive Ballon Pulmonary Angioplasty if they are suitable for this procedure according to the recommendation of the local CTEPH board (e.g. not suitable for PEA). Patients must also consent to this procedure.The BPA will be accomplished in several interventions.

Trial Locations (1)

1090

Medical Unviersity Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT03074539 - Sleep-Disordered Breathing in Chronic Thromboembolic Pulmonary Hypertension | Biotech Hunter | Biotech Hunter